Biograft, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersStanford, CA
SAM.gov UEIG9B3RNSFLTM7
Biograft develops novel medical devices intended to reduce vein graft failure in patients undergoing coronary artery bypass graft (CABG) surgery. The company addresses an unmet clinical need in the cardiovascular surgery industry, where vein grafts currently fail at high rates following CABG procedures.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Biograft, INC | Stanford | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


